GTHX - G1 Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
522
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
83,588
70,683
53,881
25,161
12,730
Selling General and Administrative
34,987
18,603
7,087
5,230
3,216
Total Operating Expenses
118,575
89,286
60,968
30,391
15,946
Operating Income or Loss
-118,575
-89,286
-60,968
-30,391
-15,424
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
7,478
3,998
847
100
-4,839
Income Before Tax
-111,097
-85,288
-60,121
-30,291
-20,263
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-111,097
-85,288
-60,121
-30,291
-20,263
Net Income
-111,097
-85,288
-60,121
-30,291
-20,263
Net Income available to common shareholders
-111,097
-85,288
-64,878
-34,696
-21,690
Reported EPS
Basic
-
-2.56
-3.57
-1.63
-1.06
Diluted
-
-2.56
-3.57
-1.63
-1.06
Weighted average shares outstanding
Basic
-
33,317
18,198
18,549
20,429
Diluted
-
33,317
18,198
18,549
20,429
EBITDA
-
-89,111
-60,879
-30,324
-15,382